Back to Search
Start Over
Daratumumab plus lenalidomide/bortezomib/dexamethasone in Black patients with transplant-eligible newly diagnosed multiple myeloma in GRIFFIN.
- Source :
-
Blood cancer journal [Blood Cancer J] 2022 Apr 13; Vol. 12 (4), pp. 63. Date of Electronic Publication: 2022 Apr 13. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 2044-5385
- Volume :
- 12
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Blood cancer journal
- Publication Type :
- Report
- Accession number :
- 35418120
- Full Text :
- https://doi.org/10.1038/s41408-022-00653-1